세계의 광역학 요법(PDT) 시장 규모, 점유율, 성장 분석 : 메커니즘별, 카테고리별, 치료법별, 소프트웨어별, 서비스별, 앱 접근성별, 용도별, 지역별 - 산업 예측(2025-2032년)

Global Photodynamic Therapy (PDT) Market size was valued at USD 4.1 billion in 2023 and is poised to grow from USD 4.93 billion in 2024 to USD 21.64 billion by 2032, growing at a CAGR of 20.3% during the forecast period (2025-2032).

The global Photodynamic Therapy (PDT) landscape is increasingly influenced by the demand for personalized and efficacy-driven treatment solutions that transcend conventional methodologies. This shift stems from a growing acknowledgment that customized therapeutic programs enhance patient engagement and clinical results, minimizing dependence on traditional pharmacological approaches. Integration of PDT into standard care routines is becoming prevalent, facilitated by clearer approval pathways established by regulatory agencies. Additionally, insurance providers are increasingly recognizing the value of PDT in managing both chronic and behavioral health conditions, driving collaborative efforts among tech companies, healthcare providers, and life-science firms. Key trends include a focus on clinical validation and partnerships between digital health innovators and established healthcare entities, addressing critical concerns around data privacy and security to ensure robust, patient-focused therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Photodynamic Therapy (PDT) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Photodynamic Therapy (PDT) Market Segments Analysis

Global Photodynamic Therapy (PDT) Market is segmented by Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients and region. Based on Mechanism, the market is segmented into Input Mechanisms and Output Mechanisms. Based on Category, the market is segmented into Medication Augmentation and Medication Replacement. Based on Treatment, the market is segmented into Outpatient Treatment and Monotherapy. Based on Software, the market is segmented into Software for Respiratory Conditions, Software for Mental Health, Software for Opioid Use Disorder, Software for Diabetes and Others. Based on Services, the market is segmented into Behavioral Microservices and Medical Microservices. Based on App Accessibility, the market is segmented into Android, iOS and Windows. Based on App Type, the market is segmented into Native Apps and Web Apps. Based on Application, the market is segmented into Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer's Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions and Others. Based on Patients, the market is segmented into Children and Adults. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Photodynamic Therapy (PDT) Market

The increasing focus on patient-centric care is significantly driving growth in the global Photodynamic Therapy (PDT) market. There is a heightened demand for therapeutic solutions that prioritize personalized support rather than relying solely on traditional medications. Prescription digital therapeutics are gaining traction, offering structured and evidence-based programs that can be tailored to the unique requirements of each patient. This evolution is particularly essential for the management of chronic and behavioral health issues, where ongoing engagement and real-time feedback play a crucial role. As patients' expectations shift, the attractiveness of customized, technology-driven treatment options continues to expand.

Restraints in the Global Photodynamic Therapy (PDT) Market

Despite the increasing interest in photodynamic therapy (PDT), there is still a significant lack of awareness among healthcare providers and patients regarding its clinical benefits and accessibility. This unfamiliarity contributes to reluctance in adopting PDT, resulting in lower prescription rates. Furthermore, the available training and educational resources are insufficient, hindering the integration of PDT into standard treatment practices. Without a deeper understanding among key stakeholders, the market potential for PDT remains largely untapped, as misconceptions and a lack of knowledge impede its acceptance and implementation in therapeutic settings.

Market Trends of the Global Photodynamic Therapy (PDT) Market

The Global Photodynamic Therapy (PDT) market is experiencing a transformative trend driven by the integration of drug-digital combination therapies. Pharmaceutical companies are forging partnerships with digital therapeutic developers to create innovative solutions that combine PDT with software-based interventions. This synergistic approach enhances treatment efficacy by modifying both patient behavior and pharmacological responses simultaneously. The incorporation of digital tools not only aids in adherence tracking but also facilitates the collection of real-world data, leading to improved therapeutic outcomes. As the demand for personalized medicine and enhanced patient care continues to rise, the PDT market is poised for significant growth, characterized by this collaborative evolution.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Photodynamic Therapy (PDT) Market Size by Mechanism & CAGR (2025-2032)

• Market Overview
• Input Mechanisms
• Output Mechanisms

Global Photodynamic Therapy (PDT) Market Size by Category & CAGR (2025-2032)

• Market Overview
• Medication Augmentation
• Medication Replacement

Global Photodynamic Therapy (PDT) Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Outpatient Treatment
• Monotherapy

Global Photodynamic Therapy (PDT) Market Size by Software & CAGR (2025-2032)

• Market Overview
• Software for Respiratory Conditions
• Software for Mental Health
• Software for Opioid Use Disorder
• Software for Diabetes
• Others

Global Photodynamic Therapy (PDT) Market Size by Services & CAGR (2025-2032)

• Market Overview
• Behavioral Microservices
• Medical Microservices

Global Photodynamic Therapy (PDT) Market Size by App Accessibility & CAGR (2025-2032)

• Market Overview
• Android
• iOS
• Windows

Global Photodynamic Therapy (PDT) Market Size by App Type & CAGR (2025-2032)

• Market Overview
• Native Apps
• Web Apps

Global Photodynamic Therapy (PDT) Market Size by Application & CAGR (2025-2032)

• Market Overview
• Substance Use Disorder (SUD)
• Opioid Use Disorder (OUD)
• Attention Deficit/Hyperactivity Disorder (ADHD)
• Alzheimer's Disease
• Major Depressive Disorder (MDD)
• Insomnia
• Epilepsy
• Movement Disorder
• Multiple Sclerosis
• Migraine
• Autism Spectrum Disorder
• Oncology
• Inflammation
• Respiratory
• Cardiovascular
• Pain Management
• Metabolic Conditions
• Others

Global Photodynamic Therapy (PDT) Market Size by Patients & CAGR (2025-2032)

• Market Overview
• Children
• Adults

Global Photodynamic Therapy (PDT) Market Size & CAGR (2025-2032)

• North America (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • US
  • Canada
• Europe (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• ResMed (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAMSUNGHEALTHCARE (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omada Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GAIA AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Welldoc's Bluestar (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Better Therapeutics, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BigHealth (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biofourmis (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Click Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Happify, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Naturalcycles Nordic AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuvoAir AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensyne Health plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations